Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is believed to be in deliberations on a takeover bid for acquiring Mylan NV (NASDAQ:MYL), according to private sources within the company. The merger would create a global generic-drug giant and would boost sales for both companies.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is said to be in internal debate over the takeover bid and no offer has materialized to date. The company has approached advisers regarding the possibility of such a bid transpiring and the financing required for an attempt of this scale.
Also read: United Technologies Keeps Eye on a Breakup